BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 32822867)

  • 1. Acetylshikonin isolated from Lithospermum erythrorhizon roots inhibits dihydrofolate reductase and hampers autochthonous mammary carcinogenesis in Δ16HER2 transgenic mice.
    Wang J; Iannarelli R; Pucciarelli S; Laudadio E; Galeazzi R; Giangrossi M; Falconi M; Cui L; Navia AM; Buccioni M; Marucci G; Tomassoni D; Serini L; Sut S; Maggi F; Dall'Acqua S; Marchini C; Amici A
    Pharmacol Res; 2020 Nov; 161():105123. PubMed ID: 32822867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo anticancer effects of Lithospermum erythrorhizon extract on B16F10 murine melanoma.
    Rajasekar S; Park DJ; Park C; Park S; Park YH; Kim ST; Choi YH; Choi YW
    J Ethnopharmacol; 2012 Nov; 144(2):335-45. PubMed ID: 22995444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetylshikonin inhibits growth of oral squamous cell carcinoma by inducing apoptosis.
    Kim DJ; Lee JH; Park HR; Choi YW
    Arch Oral Biol; 2016 Oct; 70():149-157. PubMed ID: 27371806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lithospermum erythrorhizon suppresses high-fat diet-induced obesity, and acetylshikonin, a main compound of Lithospermum erythrorhizon, inhibits adipocyte differentiation.
    Gwon SY; Ahn JY; Chung CH; Moon B; Ha TY
    J Agric Food Chem; 2012 Sep; 60(36):9089-96. PubMed ID: 22900585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sanguinarine suppresses basal-like breast cancer growth through dihydrofolate reductase inhibition.
    Kalogris C; Garulli C; Pietrella L; Gambini V; Pucciarelli S; Lucci C; Tilio M; Zabaleta ME; Bartolacci C; Andreani C; Giangrossi M; Iezzi M; Belletti B; Marchini C; Amici A
    Biochem Pharmacol; 2014 Aug; 90(3):226-34. PubMed ID: 24875448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of acetylshikonin as the novel CYP2J2 inhibitor with anti-cancer activity in HepG2 cells.
    Park SH; Phuc NM; Lee J; Wu Z; Kim J; Kim H; Kim ND; Lee T; Song KS; Liu KH
    Phytomedicine; 2017 Jan; 24():134-140. PubMed ID: 28160853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology, toxicity and pharmacokinetics of acetylshikonin: a review.
    Zhang Z; Bai J; Zeng Y; Cai M; Yao Y; Wu H; You L; Dong X; Ni J
    Pharm Biol; 2020 Dec; 58(1):950-958. PubMed ID: 32956595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylshikonin suppressed growth of colorectal tumour tissue and cells by inhibiting the intracellular kinase, T-lymphokine-activated killer cell-originated protein kinase.
    Zhao R; Choi BY; Wei L; Fredimoses M; Yin F; Fu X; Chen H; Liu K; Kundu JK; Dong Z; Lee MH
    Br J Pharmacol; 2020 May; 177(10):2303-2319. PubMed ID: 31985814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-Wide Identification of
    Wang X; He Z; Yang H; He C; Wang C; Fazal A; Lai X; Yang L; Wen Z; Yang M; Ma S; Jie W; Cai J; Yin T; Liu B; Yang Y; Qi J
    Life (Basel); 2022 Nov; 12(11):. PubMed ID: 36362930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiallergic Effects of N,N-dicoumaroylspermidine Isolated from
    Le TT; Kang TK; Lee WB; Jung SH
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roots of Lithospermum erythrorhizon promotes retinal cell survival in optic nerve crush-induced retinal degeneration.
    Kang TK; Le TT; Kim KA; Kim YJ; Lee WB; Jung SH
    Exp Eye Res; 2021 Feb; 203():108419. PubMed ID: 33383026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of acetylshikonin isolated from Lithospermum canescens roots on tumor-induced cutaneous angiogenesis.
    Pietrosiuk A; Furmanowa M; Skopińiska-Rózewska E; Sommer E; Skurzak H; Bany J
    Acta Pol Pharm; 2004; 61(5):379-82. PubMed ID: 15747695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irreversible inhibition of Δ16HER2 is necessary to suppress Δ16HER2-positive breast carcinomas resistant to Lapatinib.
    Tilio M; Gambini V; Wang J; Garulli C; Kalogris C; Andreani C; Bartolacci C; Elexpuru Zabaleta M; Pietrella L; Hysi A; Iezzi M; Belletti B; Orlando F; Provinciali M; Galeazzi R; Marchini C; Amici A
    Cancer Lett; 2016 Oct; 381(1):76-84. PubMed ID: 27475932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of β,β-dimethylacrylshikonin on hepatocellular carcinoma in vitro and in vivo.
    Wu YY; Wan LH; Zheng XW; Shao ZJ; Chen J; Chen XJ; Liu LT; Kuang WJ; Tan XS; Zhou LM
    Phytother Res; 2012 May; 26(5):764-71. PubMed ID: 22109831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetylshikonin induces apoptosis of human leukemia cell line K562 by inducing S phase cell cycle arrest, modulating ROS accumulation, depleting Bcr-Abl and blocking NF-κB signaling.
    Hao G; Zhai J; Jiang H; Zhang Y; Wu M; Qiu Y; Fan C; Yu L; Bai S; Sun L; Yang Z
    Biomed Pharmacother; 2020 Feb; 122():109677. PubMed ID: 31810012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoamine oxidase inhibitory naphthoquinones from the roots of Lithospermum erythrorhizon.
    Choi WH; Hong SS; Lee SA; Han XH; Lee KS; Lee MK; Hwang BY; Ro JS
    Arch Pharm Res; 2005 Apr; 28(4):400-4. PubMed ID: 15918512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective targeting of triple-negative breast cancer cells by PF-4942847, a novel oral inhibitor of Hsp 90.
    Mehta PP; Whalen P; Baxi SM; Kung PP; Yamazaki S; Yin MJ
    Clin Cancer Res; 2011 Aug; 17(16):5432-42. PubMed ID: 21715568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bruton's Tyrosine Kinase Inhibitors Prevent Therapeutic Escape in Breast Cancer Cells.
    Wang X; Wong J; Sevinsky CJ; Kokabee L; Khan F; Sun Y; Conklin DS
    Mol Cancer Ther; 2016 Sep; 15(9):2198-208. PubMed ID: 27256378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shikonin, acetylshikonin, and isobutyroylshikonin inhibit VEGF-induced angiogenesis and suppress tumor growth in lewis lung carcinoma-bearing mice.
    Lee HJ; Lee HJ; Magesh V; Nam D; Lee EO; Ahn KS; Jung MH; Ahn KS; Kim DK; Kim JY; Kim SH
    Yakugaku Zasshi; 2008 Nov; 128(11):1681-8. PubMed ID: 18981704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiazolo[4,5-d]pyridazine analogues as a new class of dihydrofolate reductase (DHFR) inhibitors: Synthesis, biological evaluation and molecular modeling study.
    Ewida MA; Abou El Ella DA; Lasheen DS; Ewida HA; El-Gazzar YI; El-Subbagh HI
    Bioorg Chem; 2017 Oct; 74():228-237. PubMed ID: 28865294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.